HIGHLIGHTS
- who: Joanna Schaenman from the DivisionUniversity of California Los Angeles, Los Angeles, California, USA have published the article: Preservation of Antiviral Immunologic Efficacy Without Alloimmunity After Switch to Belatacept in Calcineurin Inhibitor-Intolerant Patients, in the Journal: (JOURNAL) of 20/Oct/2022
- how: An important distinction between the study and previous reports is the study of PBMCs collected from patients receiving belatacept in contrast to previous studies in which exogenous belatacept was added to PBMCs in_vitro in healthy controls or kidney transplant patients receiving CNI.1920
SUMMARY
Risk for EBV-associated . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.